These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 1694203)

  • 1. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T; Hara T; Matsumoto M; Akedo H
    J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
    Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
    Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CR1- and membrane cofactor protein-like proteins of two primates.
    Nickells MW; Atkinson JP
    J Immunol; 1990 Jun; 144(11):4262-8. PubMed ID: 2140391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
    Marquart HV; Svehag SE; Leslie RG
    J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of lymphocyte-mediated K562 cytotoxicity by antibodies against complement membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Seya T; Kojima A; Hara T; Hazeki K; Sugita Y; Akedo H
    Immunobiology; 1991 Sep; 183(1-2):115-24. PubMed ID: 1718846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of membrane cofactor protein (CD46) in the human kidneys.
    Nakanishi I; Moutabarrik A; Hara T; Hatanaka M; Hayashi T; Syouji T; Okada N; Kitamura E; Tsubakihara Y; Matsumoto M
    Eur J Immunol; 1994 Jul; 24(7):1529-35. PubMed ID: 8026516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.
    Seya T; Nagasawa S; Atkinson JP
    J Immunol; 1990 Mar; 144(6):2312-20. PubMed ID: 1690242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element.
    Cui W; Hourcade D; Post T; Greenlund AC; Atkinson JP; Kumar V
    J Immunol; 1993 Oct; 151(8):4137-46. PubMed ID: 7691939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
    Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
    Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.